Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Analysis of Noonan syndrome cases detected in cohorts of patients with hearing loss

https://doi.org/10.25557/2073-7998.2026.06.46-54

Abstract

Noonan syndrome (NS) is a multisystem disease caused by pathogenic variants in genes involved in the RAS/MAPK signaling pathway, with pathogenic/likely pathogenic variants of the PTPN11 gene being the main causative variants in this syndrome. The clinical picture of NS includes a wide range of pathologies, including: facial dysmorphism, growth retardation, heart defects, pigmentation and intellectual development disorders, cryptorchidism, and hearing loss. The incidence of severe congenital sensorineural hearing loss and deafness in the samples of patients with NS varies from 8.7% to 19.1%. With the advent of high-throughput sequencing methods, mutations of the PTPN11 gene have increasingly become detected in non-target samples of patients with nonsyndromic hearing loss. This paper describes a case of previously undiagnosed Noonan syndrome with multiple lentiginious, identified by cascade testing, including WES analysis, in a sample of Buryat patients with congenital hearing disorders. The article discusses similar cases of identification of pathogenic variants in the PTPN11 gene identified in samples of patients with nonsyndromic hearing loss/deafness.

About the Authors

A. M. Cherdonova
M.K. Ammosov North-Eastern Federal University
Russian Federation

58 Belinskogo str., Yakutsk, 677000



T. V. Borisova
M.K. Ammosov North-Eastern Federal University
Russian Federation

58 Belinskogo str., Yakutsk, 677000



F. M. Teryutin
Yakut Scientific Center of Complex Medical Problems
Russian Federation

6/3 Yaroslavskogo str., Yakutsk, 677018



V. G. Pshennikova
Yakut Scientific Center of Complex Medical Problems
Russian Federation

6/3 Yaroslavskogo str., Yakutsk, 677018



A. V. Solovyev
M.K. Ammosov North-Eastern Federal University
Russian Federation

58 Belinskogo str., Yakutsk, 677000



S. A. Fedorova
M.K. Ammosov North-Eastern Federal University
Russian Federation

58 Belinskogo str., Yakutsk, 677000



N. A. Barashkov
Yakut Scientific Center of Complex Medical Problems
Russian Federation

6/3 Yaroslavskogo str., Yakutsk, 677018



References

1. Orlova A.A., Dadali E.L., Polyakov A.V. Clinical and Genetic Characteristics of Noonan Syndrome and Noonan-like Diseases. Russ J Genet. 2020; 56: 540–547. https://doi.org/10.1134/S1022795420050117

2. Tartaglia M., Kalidas K., Shaw A., et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70(6):1555-63. doi: 10.1086/340847.

3. Um S., Kakati T., Iakoucheva L.M., et al. Understanding Molecular Basis of PTPN11-Related Diseases. ArXiv [Preprint]. 2025:arXiv:2511.11860v1.

4. Rauen K.A. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355-69. doi: 10.1146/annurev-genom-091212-153523.

5. Roberts A.E., Allanson J.E., Tartaglia M., Gelb B.D. Noonan syndrome. Lancet. 2013;381(9863):333-42. doi: 10.1016/S0140-6736(12)61023-X.

6. Athota J.P., Bhat M., Nampoothiri S., et al. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations. BMC Med Genet. 2020;21(1):50. doi: 10.1186/s12881-020-0986-5.

7. Reynolds G., Gazzin A., Carli D., et al. Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review. Int J Mol Sci. 2025;26(8):3515. doi: 10.3390/ijms26083515.

8. Blumenthal D., Lovett B., Leonard J., et al. Cochlear Implantation in Noonan Syndrome With and Without Multiple Lentigines: A Case Report and Systematic Review. Otol Neurotol Open. 2022;2(1):e009. doi: 10.1097/ONO.0000000000000009.

9. Ciavarro G., Bacciu A., Di Lella F., Vincenti V. Noonan syndrome: cochlear implantation in the setting of cochlear nerve deficiency. Acta Biomed. 2022;93(S1):e2022113. doi: 10.23750/abm.v93iS1.11063.

10. Ni K., Fang J., Fan W., et al. Analysis of the clinical features of neurocristopathy-related hearing loss and how these relate to outcomes after cochlear implantation. Sci Rep. 2025;15(1):41227. doi: 10.1038/s41598-025-25126-w.

11. Chen Z., Bi Q., Kang B., et al. Clinical phenotypes and cochlear implant outcomes in patients with PTPN11-associated noonan spectrum disorders: Insights from a genetically screened cohort. Eur Arch Otorhinolaryngol. 2026;283(5):3073-3084. doi: 10.1007/s00405-026-10056-8.

12. Alshamrani H.M., Assaedi L.M., Bahattab J.A., et al. LEOPARD Syndrome with a Sporadic PTPN11 Mutation in a Saudi Patient. Case Rep Dermatol Med. 2023;2023:4161574. doi: 10.1155/2023/4161574.

13. Lin Y., Xu X. LEOPARD Syndrome. Int J Dermatol. 2024;63(11):1601-1602. doi: 10.1111/ijd.17219

14. Sharland M., Burch M., McKenna W.M., Paton M.A. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67(2):178-83. doi: 10.1136/adc.67.2.178.

15. Li X., Yao R., Tan X., et al. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients. Clin Genet. 2019;96(4):290-299. doi: 10.1111/cge.13588

16. Lee S.J., Jeong S., Lee S., et al. Gene signatures and genotype-phenotype correlations of sensorineural hearing loss in Noonan syndrome and related RASopathies. Sci Rep. 2025;15(1):12102. doi: 10.1038/s41598-025-90635-7.

17. Ziegler A., Loundon N., Jonard L., et al. Noonan Syndrome: An Underestimated Cause of Severe to Profound Sensorineural Hearing Impairment. Which Clues to Suspect the Diagnosis? Otol Neurotol. 2017;38(8):1081-1084. doi: 10.1097/MAO.0000000000001509.

18. Gao X., Huang S.S., Qiu S.W., et al. Congenital sensorineural hearing loss as the initial presentation of PTPN11-associated Noonan syndrome with multiple lentigines or Noonan syndrome: clinical features and underlying mechanisms. J Med Genet. 2021;58(7):465-474. doi: 10.1136/jmedgenet-2020-106892.

19. Wu J., Cao Z., Su Y., et al. Molecular diagnose of a large hearing loss population from China by targeted genome sequencing. J Hum Genet. 2022;67(11):643-649. doi: 10.1038/s10038-022-01066-5.

20. Mutai H., Momozawa Y., Kamatani Y., et al. Whole exome analysis of patients in Japan with hearing loss reveals high heterogeneity among responsible and novel candidate genes. Orphanet J Rare Dis. 2022;17(1):114. doi: 10.1186/s13023-022-02262-4.

21. Bademci G., Cengiz F.B., Foster I. J., et al. Variations in Multiple Syndromic Deafness Genes Mimic Non-syndromic Hearing Loss. Sci Rep. 2016;6:31622. doi: 10.1038/srep31622

22. Sloan-Heggen C.M., Bierer A.O., Shearer A.E., et al. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet. 2016;135(4):441-450. doi: 10.1007/s00439-016-1648-8.

23. Sarkozy A., Conti E., Digilio M.C., et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet. 2004;41(5):e68. doi: 10.1136/jmg.2003.013466.

24. Motegi S., Yokoyama Y., Ogino S., et al. Pathogenesis of multiple lentigines in LEOPARD syndrome with PTPN11 gene mutation. Acta Derm Venereol. 2015;95(8):978-84. doi: 10.2340/00015555-2123. PMID: 25917897.

25. Vermeire K., Wexler L., Vambutas A. The experience of bilateral cochlear implantation in a child with LEOPARD syndrome. Int J Pediatr Otorhinolaryngol. 2016;90:125-127. doi: 10.1016/j.ijporl.2016.09.013.


Review

For citations:


Cherdonova A.M., Borisova T.V., Teryutin F.M., Pshennikova V.G., Solovyev A.V., Fedorova S.A., Barashkov N.A. Analysis of Noonan syndrome cases detected in cohorts of patients with hearing loss. Medical Genetics. 2026;25(6):46-54. (In Russ.) https://doi.org/10.25557/2073-7998.2026.06.46-54

Views: 112

JATS XML

ISSN 2073-7998 (Print)